Immunosuppressive therapy in lupus nephritis - The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

Tarih
2002
Yazar
ABRAMOVICZ, D
HOUSSIAU, FA
VASCONCELOS, C
D'CRUZ, D
SEBASTIANI, GD
GARRIDO, ED
DANIELI, MG
BLOCKMANS, D
MATHIEU, A
DIRESKENELI, H
GALEAZZI, M
LEVY, Y
PETERA, P
POPOVIC, R
PETROVIC, R
SINICO, RA
CATTANEO, R
FONT, J
DEPRESSEUX, G
COSYNS, JP
CERVERA, R
Gul, Ahmet
Üst veri
Tüm öğe kaydını göster
Özet
Objective. Glomerulonephritis is a severe manifestation of systemic lupus erythematosus (SLE) that is usually treated with an extended course of intravenous (IV) cyclophosphamide (CYC). Given the side effects of this regimen, we evaluated the efficacy and the toxicity of a course of low-dose IV CYC prescribed as a remission-inducing treatment, followed by azathioprine (AZA) as a remission-maintaining treatment.
Bağlantı
http://hdl.handle.net/20.500.12627/114959
https://doi.org/10.1002/art.10461
Koleksiyonlar